Talk:Primaquine

message: I have removed the bits about primaquine not being effective against the erythrocytic stages of malaria as untrue. Primaquine is very effective against the erythrocytic stages of malaria, but is always given with chloroquine because the effect against hypnozoites is potentiated by quinine or chloroquine.  I have referenced this statement in the article. --Gak 18:04, 13 January 2007 (UTC)
replies: text: Certainly anecdotal and WP:OR but...in late 70's Peace Corps Volunteers were given a dose of primaquine to be taken 4 days after leaving malarial endemic areas. Since at that time weekly chloroquine was the PC prophylaxis of choice (at least in West Africa), the number of days from the last chloroquine dose could have been as long as 11 days but no more. Juan Riley (talk) 18:56, 24 August 2014 (UTC)
thread_title: Radical cure

message: Our group is planning to make the following changes to the page in the next two weeks:
* Flesh out the lede (3-4 paragraph style)
* Update adverse reactions section and nest the contraindications section
* Remove Manufacturing and Availability section, relocate and condense pertinent information to the lede
* Add a pharmacokinetics section (incorporate Dosing section)
* Add a Mechanism of Action section
* Move dosing for continuity and update  — Preceding unsigned comment added by Dgarcia24 (talk • contribs) 07:45, 9 November 2016 (UTC)
replies: text: We don't discuss dosing per WP:MEDMOS.  Unclear if the information that was under "manufacturing" is true; moved it here until someone verifies it (note - the "testing at prison" if true really belongs under History per MEDMOS).  The refs in this article are all very old.  It could use a complete workover based on recent MEDRS sources for the WP:Biomedical information  content and WP:RS for the rest. Jytdog (talk) 18:53, 3 November 2016 (UTC)

text: We don't discuss dosing per WP:MEDMOS.  Jytdog (talk) 08:16, 9 November 2016 (UTC)
thread_title:  Ongoing Edits through 11/17 (UCSF Health Policy Course) 

message: moving this here as it is unsourced per PRESERVE
:Manufacturing and availability
Primaquine was first tested on humans during the Stateville Penitentiary Malaria Study in 1944. Primaquine was licensed for use in the USA by the Food and Drug Administration in 1952 and is available as a generic drug from a variety of manufacturers.
Primaquine is not licensed for use in the United Kingdom. It is available on a named patient basis only from certain pharmaceutical providers. Primaquine tablets available in the UK contain 7.5 mg primaquine base (13.2 mg phosphate salt). Primaquine tablets available in the US contain 15 mg base (26.3 mg phosphate salt).\
-- 18:50, 3 November 2016 (UTC)
thread_title:  unsoured 

message: 1.	STUDENT 1 – Does the draft submission reflect a neutral point of view? If not, specify…
Yes, the draft submission on Primaquine reflects a neutral point of view. There is no evidence of editorial bias. The editing group drew information from reliable sources, and there was no original research used to validate statements within the article. --Lois.chung (talk) 17:39, 15 November 2016 (UTC)
thread_title:  Review for CP 133 

message: Would it be appropriate to add this section? I thought I’d do a sentence or two about the M*A*S*H episode that deals extensively with side effects. AutumnAdrift (talk) 06:06, 29 May 2022 (UTC)
thread_title:  “In Popular Culture”